Zobrazeno 1 - 10
of 54
pro vyhledávání: '"H A Bonte"'
Autor:
Vera E. IJmker-Hemink, Nina Kooijman, Yvonne J. L. Kamm, Rutger H. T. Koornstra, Johanna N. H. Timmer-Bonte, Geert J. A. Wanten, Manon G. A. van den Berg
Publikováno v:
Cancer Care Research Online. 3:e038
Autor:
M. Folsche, J. H. P. Evers, J. M. E. van Wijck, E. M. M. van den Bergh, J. N. H. Timmer-Bonte, G. J. L. Kaspers, S. E. J. Kaal
Publikováno v:
Leerboek oncologieverpleegkunde ISBN: 9789036826440
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db9a1fe0719d0efd7f52ad2c336821d3
https://doi.org/10.1007/978-90-368-2645-7_6
https://doi.org/10.1007/978-90-368-2645-7_6
Autor:
J N H, Timmer-Bonte, J, Ouwerkerk, L M, Faber, L G M, Kerkhofs, L, Laterveer, D, Ten Oever, B P, van Rees, P W, van der Linden
Publikováno v:
The Netherlands journal of medicine. 78(5)
Chemotherapy (CT)-induced neutropenia and febrile neutropenia (FN) can lead to changes in the treatment plan, potentially worsening the cancer outcome. This study evaluated the effect of the glycopegylated granulocyte-colony stimulating factor lipegf
Autor:
Nicole Buist, Hanneke W. M. van Laarhoven, Anja de Kruif, Maartje Los, Lisette Kamps, Dieuwertje E. Kok, Johanna N. H. Timmer-Bonte, Maud M. Geenen, Renate M. Winkels, A. Haringhuizen, Ellen Kampman, Rianne van Lieshout, Celine S. Kelfkens, Joan B. Heijns, Liesbeth Posthuma, Dirkje W. Sommeijer, Maaike M.G.A. van den Berg
Publikováno v:
Breast Cancer Research and Treatment, 173, 475-481
Breast Cancer Research and Treatment, 173(2), 475-481. Springer New York
Breast cancer research and treatment, 173(2), 475-481. Springer New York
Breast Cancer Research and Treatment, 173, 2, pp. 475-481
van den Berg, M M G A, Kok, D E, Posthuma, L, Kamps, L, Kelfkens, C S, Buist, N, Geenen, M, Haringhuizen, A, Heijns, J B, van Lieshout, R H M A, Los, M, Sommeijer, D W, Timmer-Bonte, J N H, de Kruif, A T C M, van Laarhoven, H W M, Kampman, E & Winkels, R M 2019, ' Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy ', Breast Cancer Research and Treatment, vol. 173, no. 2, pp. 475-481 . https://doi.org/10.1007/s10549-018-5014-5
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 173(2), 475-481
Breast Cancer Research and Treatment 173 (2019) 2
Breast Cancer Research and Treatment, 173(2), 475-481. Springer New York
Breast cancer research and treatment, 173(2), 475-481. Springer New York
Breast Cancer Research and Treatment, 173, 2, pp. 475-481
van den Berg, M M G A, Kok, D E, Posthuma, L, Kamps, L, Kelfkens, C S, Buist, N, Geenen, M, Haringhuizen, A, Heijns, J B, van Lieshout, R H M A, Los, M, Sommeijer, D W, Timmer-Bonte, J N H, de Kruif, A T C M, van Laarhoven, H W M, Kampman, E & Winkels, R M 2019, ' Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy ', Breast Cancer Research and Treatment, vol. 173, no. 2, pp. 475-481 . https://doi.org/10.1007/s10549-018-5014-5
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 173(2), 475-481
Breast Cancer Research and Treatment 173 (2019) 2
Purpose Initial dose of chemotherapy is planned based on body surface area, which does not take body composition into account. We studied the association between fat mass (kg and relative to total body weight) as well as lean mass (kg and relative to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::340cbbf2e9ab0fd05d298c37619d2fc1
http://hdl.handle.net/2066/203299
http://hdl.handle.net/2066/203299
Autor:
Suzan van der Meij, Herman van Wietmarschen, Emine Göker, Inge Boers, Arjan P Schouten van der Velden, Anja N J H Timmer-Bonte, Miek C. Jong
Publikováno v:
Journal of alternative and complementary medicine (New York, N.Y.). 24(9-10)
To compare the effectiveness of yoga added to standard care (SC) versus SC only, in women with breast cancer during chemotherapy.A multicenter pragmatic, randomized controlled study.Three hospitals in the Netherlands.Women with stage I-III breast can
Autor:
Johanna N. H. Timmer-Bonte, Monique Roukens, Michiel W. H. van Beek, C. Kramers, Wilco C. H. Jacobs
Publikováno v:
Drugs-Real World Outcomes
Background Few studies have assessed the safety and effectiveness of the numerous available chemotherapeutic therapies for geriatric oncology patients. Most safety studies are conducted in large trials, and there is some uncertainty surrounding wheth
Autor:
Sjoerd G. Elias, Thijs van Dalen, Emiel J. Th. Rutgers, Anne Kuijer, Joost van Gorp, Marieke E. Straver, Johanna N. H. Timmer-Bonte, Sabine Siesling, Tineke J. Smilde, Jelle Wesseling, Julia E.C. van Steenhoven, Charlotte F.J.M. Blanken, Paul J. van Diest, Alex L.T. Imholz, Peter Nieboer
Publikováno v:
Genes, 9, 5
Genes
Genes, 9(5). Multidisciplinary Digital Publishing Institute (MDPI)
Genes, 9(5):261. MDPI
Genes; Volume 9; Issue 5; Pages: 261
Genes, 9
Genes
Genes, 9(5). Multidisciplinary Digital Publishing Institute (MDPI)
Genes, 9(5):261. MDPI
Genes; Volume 9; Issue 5; Pages: 261
Genes, 9
In this study, in estrogen receptor positive (ER+) early stage breast cancer patients who were considered candidates for 70-gene signature (70-GS, “MammaPrint”) use, we compared molecular subtyping (MS) based on the previously validated 80-gene s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91edc345dbbc4760cadbc9b4c69d841d
https://doi.org/10.3390/genes9050261
https://doi.org/10.3390/genes9050261
Autor:
Edwin A. Usmanij, Tinatin Natroshvili, Johanna N. H. Timmer-Bonte, Lioe-Fee de Geus-Oei, Wim J.G. Oyen, Johan Bussink, Miep A. van der Drift
Publikováno v:
The Journal of Nuclear Medicine (1978), 58, 1243-1248
The Journal of Nuclear Medicine (1978), 58, 8, pp. 1243-1248
Journal of Nuclear Medicine, 58(8), 1243-1248
The Journal of Nuclear Medicine (1978), 58, 8, pp. 1243-1248
Journal of Nuclear Medicine, 58(8), 1243-1248
Contains fulltext : 177483.pdf (Publisher’s version ) (Closed access) 18F-FDG PET/CT is potentially applicable to predict response to chemotherapy in combination with bevacizumab in patients with advanced non-small cell lung cancer (NSCLC). Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f719f8fd93f8008fe5a99c37aa16820a
http://hdl.handle.net/2066/177483
http://hdl.handle.net/2066/177483
Autor:
Edwin A, Usmanij, Tinatin, Natroshvili, Johanna N H, Timmer-Bonte, Wim J G, Oyen, Miep A, van der Drift, Johan, Bussink, Lioe-Fee de, Geus-Oei
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 58(8)
Autor:
E F M M, van Dijk, M, Coşkuntürk, A T, Zuur, J, van der Palen, W T A, van der Graaf, J N H, Timmer-Bonte, A N M, Wymenga
Publikováno v:
The Netherlands journal of medicine. 74(7)
In the past years, interest in patient treatment preferences is growing. Our objectives were: (1) to assess and compare the minimal required benefit for patients with cancer, patients without cancer and healthcare professionals to make chemotherapy a